A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies
Clinical trial NCT05932173 · UNKNOWN
Trial details
- NCT number
- NCT05932173
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.